Oncolys BioPharma Inc. (4588.T) JPX
Currency In JPY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 35.6B |
| Enterprise Value | 32.25B |
| P/E Ratio | -42.11 |
| PEG Ratio | -1.18 |
| Price/Sales Ratio | 2,096.51 |
| Price/Book Ratio | 21.72 |
| Enterprise/Revenue | 2,007.62 |
| Enterprise/EBITDA | -38.27 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -52.5 |
| Operating Margin | -52.46 |
AD
Management Effectiveness
| Return On Assets | -0.37 |
| Return On Equity | -0.61 |
Income Statement
| Revenue | 28.55M |
| Revenue/Share | 1.08 |
| Gross Profit | 28.3M |
| EBITDA | -2.05B |
| Net Income | -2.06B |
| Diluted EPS | -80 |
Balance Sheet
| Total Cash | 3.54B |
| Total Cash/Share | 120.79 |
| Total Debt | 724.12M |
| Total Debt/Equity | 0.2 |
| Current Ratio | 5.12 |
| Book Value Per Share | 122.73 |
Price History
| 52-Week Change | 350.17 |
| 52-Week High | 3,695 |
| 52-Week Low | 571 |
| Moving Average 50 Days | 2,651.46 |
| Moving Average 200 Days | 2,051.79 |
Statistics
| Average Volume | 1.26M |
| Shares Outstanding | 24.89M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
